Supernus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. It offers Qelbree, a non-stimulant indicated for the treatment of attention-deficit...
25 insider purchases on record · latest filing 2019-08-27.
Insiders have also filed 199 sale transactions at SUPN.